Oruka Therapeutics Inc. Common Stock vs RUM Group Inc. Class A Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while RUM Group Inc. Class A Common Stock trades at $6 (market cap $2.68B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, RUM Group Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and RUM Group Inc. Class A Common Stock for 0 Days on average.
| ORKA | RUM | |
|---|---|---|
Market Cap | $5.18B | $2.68B |
Volume | 490,798 | 3,201,203 |
Sector | Health | Media |
52-Week High | $113.08 | $10.23 |
52-Week Low | $26.19 | $4.67 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $2.98B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →RUM Group Inc., formerly Rumble Inc., is a holding company operating two business units: Rumble, an online video-sharing platform, and Quake AI, a cloud computing and artificial-intelligence infrastructure business.
Read more on RUM →